Abstract

BackgroundGastrointestinal stromal tumours are rare (GIST). However, the incidence of GIST among neurofibromatosis type 1 (NF-1) patients is approximately 3.9-25%. GIST can present clinically in different ways such as abdominal pain, gastrointestinal bleeding and obstruction.Case reportWe present 51 year female patient admitted with Background of neurofibromatosis type 1 admitted with melena. OGD has been done and showed duodenitis with large volume fresh blood in distal duodenum but no obvious bleeding point. Exploratory laparotomy revealed smooth nodular masses on the serosal surface of jejunum. Small bowel resection and side-to-side anastomosis were performed. Histopathoogical examination revealed small bowel gasrointestinal stromal tumour with low risk malignant potential.ConclusionThe incidence of GIST among neurofibromatosis type 1 (NF-1) patients is not uncommon and we should pay attention to gastrointestinal manifestation in such patients.

Highlights

  • Neurofibromatosis is an autosomal dominant disorder that affects all 3 germinal layers; thereby affecting any organ system

  • Gastrointestinal stromal tumours are rare (GIST) are usually located in the stomach and small intestine and can present in a variety of different ways ranging from vague symptoms to major G.I. bleeding

  • The first line treatment is surgical resection for operable GIST and 5year survival ranges from 21% to 88% depending on risk grading and completeness of surgical resection [3,4]

Read more

Summary

Introduction

Neurofibromatosis is an autosomal dominant disorder that affects all 3 germinal layers; thereby affecting any organ system. Gastrointestinal stromal tumours (GIST) are generally rare ; the incidence of GIST among NF-1 patients is approximately 5-25% [2]. GISTs are usually located in the stomach and small intestine and can present in a variety of different ways ranging from vague symptoms to major G.I. bleeding. The first line treatment is surgical resection for operable GIST and 5year survival ranges from 21% to 88% depending on risk grading and completeness of surgical resection [3,4].

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.